Menopausal hormone therapy and the breast: review of clinical studies.
This article is based on a selective literature search for relevant studies regarding HRT use and the risk of breast cancer in general population or BRCA carriers, risk of breast cancer recurrence or risk for breast cancer in situ (BCIS).
Summary:
HRT can lead to little or no increase in breast cancer risk. The risk depends on the duration and composition of the HRT and decreases after stopping the treatment. Data assessing the oncological safety of HRT after breast cancer is inconsistent. According to current knowledge HRT is fundamentally contraindicated after breast cancer but can be individually considered after risk...
Source: Breast Care - March 17, 2023 Category: Cancer & Oncology Source Type: research
News from the San Antonio Breast Cancer Symposium 2022
(Source: Breast Care)
Source: Breast Care - March 16, 2023 Category: Cancer & Oncology Source Type: research
Expert Discussion: News from the San Antonio Breast Cancer Symposium 2022
none (Source: Breast Care)
Source: Breast Care - March 16, 2023 Category: Cancer & Oncology Source Type: research
Gonadotropin-Releasing Hormone Agonists During Gonadal Chemotherapy for the Effect on Pregnancy Outcome and Ovarian Function in Premenopausal Patients With Breast Cancer: A Systematic Review and Meta-Analysis
Conclusion：For premenopausal breast cancer patients receiving gonadal toxic chemotherapy, adjuvant chemotherapy with GnRHa can better protect the ovarian function of patients, reduce the rat e of premature ovarian failure and amenorrhea, and improve the pregnancy rate, menstrual recovery rate, disease-free survival rate and overall survival rate of patients. (Source: Breast Care)
Source: Breast Care - March 13, 2023 Category: Cancer & Oncology Source Type: research
The Evolution of Educational Events during the COVID-19 Pandemic: The Experience of G.Re.T.A. Foundation
We report on the experience of G.Re.T.A. Fondazione in organizing international conferences, webinars, and masterclasses on oncoplastic and aesthetic breast surgery before, during, and after the pandemic.Results: The organization of the meetings as online or hybrid events allowed to maintain a high number of participants with numbers being in line with those achieved in the traditional face-to-face events or even showing an increased number of participants, in particular from countries not traditionally involved such as Saudi Arabia, the United Arab Emirates, India, and Russian Federation.Discussion: We think that the hybr...
Source: Breast Care - March 7, 2023 Category: Cancer & Oncology Source Type: research
The evolution of educational events during the COVID-19 pandemic: the experience of G.Re.T.A. Foundation
We report on the experience of G.Re.T.A. Fondazi one in organizing international conferences, webinars and masterclasses on oncoplastic and aesthetic breast surgery before, during and after the pandemic.
Results
The organization of the meetings as online or hybrid events allowed to maintain a high number of participants with numbers being in li ne with those achieved in the traditional face-to-face events or even showing an increased number of participants, in particular from Countries not traditionally involved as Saudi Arabia, United Arab Emirates, India and Russian Federation.
Discussion
We think that the hybrid mo...
Source: Breast Care - March 7, 2023 Category: Cancer & Oncology Source Type: research
Management of Idiopathic Granulomatous Mastitis: A Single Institution Experience
Conclusion: Incision and drainage in combination with a low dose of steroids can give an acceptable outcome with a low rate of recurrence.Breast Care (Source: Breast Care)
Source: Breast Care - February 20, 2023 Category: Cancer & Oncology Source Type: research
Management of Idiopathic Granulomatous Mastitis; a single institution experience
Conclusion
Incision and drainage in combination with a low dose of steroids can give an acceptable outcome with a low rate of recurrence. (Source: Breast Care)
Source: Breast Care - February 20, 2023 Category: Cancer & Oncology Source Type: research
PharmaNews
Breast Care 2023;18:78 –79 (Source: Breast Care)
Source: Breast Care - February 16, 2023 Category: Cancer & Oncology Source Type: research
Phytoestrogen Treatment for Menopausal Vasomotor Symptoms after Breast Cancer
Conclusion: As we cannot prove a benefit of plant extracts in the treatment of menopausal symptoms in breast cancer patients, different herbal preparations should be analyzed in randomized controlled trials in order to find sufficient and safe new treatment options for symptomatic menopausal breast cancer patients. A focus should also be laid on developing a core outcome set to simplify pooling of differe nt studies. (Source: Breast Care)
Source: Breast Care - February 15, 2023 Category: Cancer & Oncology Source Type: research
Augmented Reality in Breast Surgery Education
Conclusion: Surgical telementoring and impalpable tumors non-invasive localization are two examples that can have success in the future provided the improvements in both data transformation and infrastructures are capable to overcome the current challenges and limitations. (Source: Breast Care)
Source: Breast Care - February 8, 2023 Category: Cancer & Oncology Source Type: research
